Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00605_DB00930> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00605_DB00930 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00605_DB00930 label "DDI between Sulindac and Colesevelam - The bile acid sequestrant, colesevelam, may decrease the absorption of the NSAID, sulindac. Sulindac should be administered at least 1 hour before or 4 hours after colesevelam. Monitor for changes in the therapeutic and adverse effects of sulindac if colesevelam is initiated, discontinued or dose changed. [drugbank_resource:DB00605_DB00930]" assertion.
- drugbank_resource:DB00605_DB00930 identifier "drugbank_resource:DB00605_DB00930" assertion.
- drugbank_resource:DB00605_DB00930 title "DDI between Sulindac and Colesevelam - The bile acid sequestrant, colesevelam, may decrease the absorption of the NSAID, sulindac. Sulindac should be administered at least 1 hour before or 4 hours after colesevelam. Monitor for changes in the therapeutic and adverse effects of sulindac if colesevelam is initiated, discontinued or dose changed." assertion.